Friday, January 25, 2013- Will the Stock Market Bulls Keep Running?at CNBC (Fri, Jan 25)
- Earnings Season: It's All About Expectationsat Motley Fool (Fri, Jan 25)
- Abbott Labs -- Not AbbVie -- Is Acting Like a Spinoffat Motley Fool (Fri, Jan 25)
- Cramer's Game Plan: CAT, YHOO and 10 Other Hot Stocksat CNBC (Fri, Jan 25)
- [video] Gameplan for Next Week's Earningsat CNBC (Fri, Jan 25)
- 4 Healthcare Stock Stories for Weekend Wellnessat Wall St. Cheat Sheet (Fri, Jan 25)
- Earnings Buzz: What to Watch in the Week Aheadat CNBC (Fri, Jan 25)
- UnitedHealth buys Boston IT firm; deal worth hundreds of millions: Reportat bizjournals.com (Fri, Jan 25)
- Will This Irritable Bowel Syndrome Drug Be a Cash Cow?at Motley Fool (Fri, Jan 25)
- Pfizer Receives FDA Approval For The Use Of Prevnar 13 In Vaccine-Naive Children And Adolescents Aged 6 Years Through 17 Years For The Prevention Of Invasive Pneumococcal DiseaseBusiness Wire (Fri, Jan 25)
- [video] Earnings Calendar: Caterpillar, Exxon & Moreat CNBC (Fri, Jan 25)
- Sources: Boston's Humedica acquired by UnitedHealth Group in deal valued in 'hundreds of millions'at bizjournals.com (Fri, Jan 25)
- Pfizer Depression Drug Succeeds in Trialat Motley Fool (Fri, Jan 25)
- Week Ahead: Jobs Report, FOMC Meeting and Earningsat Fox Business (Fri, Jan 25)
- Earnings Preview: Pfizer to focus on new drug OKsAP (Fri, Jan 25)
- Bright Horizons Soars In IPO, Priced Above Estimateat Investor's Business Daily (Fri, Jan 25)
- Pfizer's Success Plan: Streamline Business And Introduce New Drugsat Seeking Alpha (Fri, Jan 25)
- A Biopharmaceutical Lottery Ticketat Motley Fool (Fri, Jan 25)
- The Big Gamble of CETP Inhibitorsat Forbes (Fri, Jan 25)
- Boehringer’s Lung Drug’s Benefits Questionedat Bloomberg (Fri, Jan 25)
- Pfizer Inc Stock Buy Recommendation Reiterated (PFE)at TheStreet (Fri, Jan 25)
Thursday, January 24, 2013Add PFE News to My Yahoo!   | |
|
0.52(1.81%) 4:00PM EDT|After Hours
:
29.47